Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study.
about
Unwinding focal segmental glomerulosclerosisChanges in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.Extrarenal determinants of kidney filter function.suPAR and chronic kidney disease-a podocyte story.Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children.
P2860
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Soluble Urokinase-type Plasmin ...... d Malmö Diet and Cancer Study.
@en
Soluble Urokinase-type Plasminogen Activator Receptor
@nl
type
label
Soluble Urokinase-type Plasmin ...... d Malmö Diet and Cancer Study.
@en
Soluble Urokinase-type Plasminogen Activator Receptor
@nl
prefLabel
Soluble Urokinase-type Plasmin ...... d Malmö Diet and Cancer Study.
@en
Soluble Urokinase-type Plasminogen Activator Receptor
@nl
P2093
P2860
P50
P1433
P1476
Soluble Urokinase-type Plasmin ...... d Malmö Diet and Cancer Study.
@en
P2093
Anders Christensson
Christina-Alexandra Schulz
Gunnar Engström
Peter Almgren
Peter M Nilsson
P2860
P304
P356
10.1016/J.EKIR.2016.11.004
P577
2017-03-01T00:00:00Z